arrow-small-left Created with Sketch. arrow-small-right Created with Sketch. Carat Left arrow Created with Sketch. check Created with Sketch. circle carat down circle-down Created with Sketch. circle-up Created with Sketch. clock Created with Sketch. difficulty Created with Sketch. download Created with Sketch. email email Created with Sketch. facebook logo-facebook Created with Sketch. logo-instagram Created with Sketch. logo-linkedin Created with Sketch. linkround Created with Sketch. preptime Created with Sketch. print Created with Sketch. Created with Sketch. twitter logo-twitter Created with Sketch.

This webinar includes key points to consider prior to prescribing menopausal hormone therapy (MHT), including treatment options, analysis of benefits and risks, and potential side effects.

Last updated: 22 September 2020 | Last reviewed: 30 March 2017

Chapters

CPD Information

Learning objectives
  1. Identify contraindications to HRT/MHT, with particular attention to breast cancer risk and venous thrombo-embolic event (VTE) risk
  2. Discuss treatment options for HRT/MHT
  3. Outline correct dosages and potential side effects of HRT/MHT (patient safety)
  4. Discuss the cessation of HRT/MHT and non-hormonal treatment options
RACGP QI&CPD Program

This webinar is activity number 185299. It is accredited with 2 category 2 CPD points.

NOTE: This is a Category 2 activity, and does not count towards a GP's RANZCOG accreditation.

Download the RACGP feedback form.

Resources

Evaluation

​To receive a certificate of completion and/or RACGP QI&CPD points, complete the evaluation survey below: